Eagle Bay Advisors’s Biogen BIIB Stock Holding History

Eagle Bay Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-9	Closed	-$1.38K	–	215
2024 Q4	$1.38K	Sell	9 -17	-65%	-$2.87K	﹤0.01%	922
2024 Q3	$5.04K	Hold	26	–	–	﹤0.01%	1006
2024 Q2	$6.03K	Hold	26	–	–	﹤0.01%	666
2024 Q1	$5.61K	Buy	26 +17	+189%	+$3.98K	﹤0.01%	697
2023 Q4	$2.33K	Hold	9	–	–	﹤0.01%	726
2023 Q3	$2.31K	Hold	9	–	–	﹤0.01%	746
2023 Q2	$2.56K	Sell	9 -152	-94%	-$45.2K	﹤0.01%	736
2023 Q1	$44.8K	Hold	161	–	–	0.02%	404
2022 Q4	$44.6K	Sell	161 -31	-16%	-$8.76K	0.03%	400
2022 Q3	$51K	Sell	192 -20	-9%	-$4.25K	0.03%	332
2022 Q2	$43.2K	Buy	+212	New	+$43.3K	0.03%	397
2022 Q1	–	Sell	-223	Closed	-$54K	–	370
2021 Q4	$54K	Sell	223 -131	-37%	-$33.7K	0.03%	349
2021 Q3	$100K	Buy	354 +177	+100%	+$58K	0.06%	240
2021 Q2	$62K	Buy	+177	New	+$53.6K	0.05%	268

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Eagle Bay Advisors's BIIB Position: Q1 2025 in Review

Eagle Bay Advisors sold out of Biogen (BIIB) in Q1 2025, closing a stake of 9 shares — an estimated $1.38K sold.

Eagle Bay Advisors first reported a position in BIIB in Q2 2021 and held it in 14 quarters. The position peaked at $100K in Q3 2021. 883 funds tracked by Wall St. Rank hold BIIB as of Q1 2025.

Eagle Bay Advisors reported no remaining Biogen position as of Q1 2025 after selling out during the quarter.
Eagle Bay Advisors sold 9 Biogen shares in Q1 2025, an estimated $1.38K.
Eagle Bay Advisors first reported a position in Biogen in Q2 2021 and held it in 14 quarters.
Eagle Bay Advisors's Biogen position peaked at $100K in Q3 2021.
883 funds tracked by Wall St. Rank held Biogen as of Q1 2025.

Based on Eagle Bay Advisors's 13F filing for Q1 2025, filed 5 May 2025.